Cite
HARVARD Citation
Ascher, B. et al. (2020). Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines. Aesthetic surgery journal. pp. 93-104. [Online].